4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-22-028157
President and CEO acquired 637,531 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bashan Dror President and CEO | 2022-02-25 | Grant or award | +637,531 | 1,085,458 | I |
Loading xslF345X03/tm227910-1_4seq1.xml…